SEC Form 4 · accession 0001246360-15-002134
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey H Burbank
Officer — Chief Executive Officer · Director
Period of report
May 12, 2015
Accepted (ET)
May 13, 2015 · 4:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2015 | M | 10,000 | $2.11 | A | 886,756 | D | |
| Common StockF2 | May 12, 2015 | S | 10,000 | $16.44 | D | 876,756 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.11 | May 12, 2015 | M | 10,000 | D | Apr 5, 2009 | Mar 4, 2016 | Common Stock | 10,000 | 139,274 | D |
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2014.
- F2This represents the weighted average price for shares sold in multiple transactions at prices ranging from $15.95 to $16.72, inclusive. Full information regarding the number of shares sold at each separate price within the range will be provided to NxStage Medical, Inc., any security holder of NxStage Medical, Inc. or the staff of the Securities and Exchange Commission, upon request.